BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27998447)

  • 1. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of adjuvant chemoradiotherapy on survival after R0 resection for stage III-N2 nonsmall cell lung cancer: A meta-analysis.
    Li D; Li W; Pang Y; Xu L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(28):e29580. PubMed ID: 35839033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma-like carcinoma: A large cohort from a single center.
    Yu X; Wen Y; Qin R; Lin Y; Zhang X; Wang W; Chen Y; Zhang L
    Thorac Cancer; 2018 Mar; 9(3):360-367. PubMed ID: 29327422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803.
    Jaklitsch MT; Gu L; Demmy T; Harpole DH; D'Amico TA; McKenna RJ; Krasna MJ; Kohman LJ; Swanson SJ; DeCamp MM; Wang X; Barry S; Sugarbaker DJ;
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):9-16. PubMed ID: 23768804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence/prognosis estimation using a molecularly positive surgical margin-based model calls for alternative curative strategies in pIIIA/N2 NSCLC.
    Li L; He K; Zhou T; Xu Y; Pang J; Yu Q; Gao Y; Shi H; Zhu H; Li M; Yu J; Yuan S
    Mol Oncol; 2024 Jun; 18(6):1649-1664. PubMed ID: 38327028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contralateral Nodal Relapse in Well-lateralised Oral Cavity Cancers Treated Uniformly with Ipsilateral Surgery and Adjuvant Radiotherapy With or Without Concurrent Chemotherapy: a Retrospective Study.
    Swain M; Budrukkar A; Murthy V; Pai P; Kanoja A; Ghosh-Laskar S; Deshmukh A; Pantvaidya G; Kannan S; Patil VM; Naronha V; Prabhash K; Sinha S; Kumar A; Gupta T; Agarwal J
    Clin Oncol (R Coll Radiol); 2024 May; 36(5):278-286. PubMed ID: 38365518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival analysis of 1,742 patients with stage IV non-small cell lung cancer].
    Peng H; Ma M; Han B
    Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):362-6. PubMed ID: 21496437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy.
    Lopez Guerra JL; Gomez DR; Lin SH; Levy LB; Zhuang Y; Komaki R; Jaen J; Vaporciyan AA; Swisher SG; Cox JD; Liao Z; Rice DC
    Ann Oncol; 2013 Jan; 24(1):67-74. PubMed ID: 23002278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrence.
    Ohtaki Y; Nagashima T; Okano N; Kubo N; Ohtaka T; Sunaga N; Sakurai R; Miura Y; Nakazawa S; Kawatani N; Yazawa T; Yoshikawa R; Narusawa E; Shirabe K
    Thorac Cancer; 2024 Apr; 15(11):859-866. PubMed ID: 38414316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel, cisplatin and 5-fluorouracil adjuvant chemotherapy following three-field lymph node dissection for stage II/III N1, 2 esophageal cancer.
    Hashiguchi T; Nasu M; Hashimoto T; Kuniyasu T; Inoue H; Sakai N; Ouchi K; Amano T; Isayama F; Tomita N; Iwanuma Y; Tsurumaru M; Kajiyama Y
    Mol Clin Oncol; 2014 Sep; 2(5):719-724. PubMed ID: 25054036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of recurrence in breast cancer patients with pathological partial response.
    Trabulus FDC; Nazli MA; Arslan E; Mermut O; Dal F; Akce B; Gursu RU; Talu ECK; Couteau JNA
    Rev Assoc Med Bras (1992); 2024; 70(3):e20231215. PubMed ID: 38656005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift.
    Zhang W; Zhang Y; Ouyang WW; Fa Su S; Ma Z; Li QS; Gang Yang W; Xia Chen X; Liu J; Lu B
    Cancer Radiother; 2024 Apr; 28(2):152-158. PubMed ID: 38320903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the "PACIFIC" Era.
    Adachi H; Ito H; Isaka T; Murakami K; Miura J; Kikunishi N; Shigeta N; Saito H; Yoshida D; Yokose T; Saito A
    Clin Lung Cancer; 2023 Dec; 24(8):733-742. PubMed ID: 37543472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics, survival analysis and influencing factors of distant metastasis in patients with acromelanomas: A retrospective study.
    Fang Y; Yongqian Z; Yin L; Li M; Mei Z; Jing Y; Di W
    Medicine (Baltimore); 2024 Jun; 103(23):e38230. PubMed ID: 38847674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of disease recurrence after radical resection and adjuvant chemotherapy in patients with stage IIb-IIIa squamous cell lung cancer: A retrospective analysis.
    Senchukova MA; Kalinin EA; Volchenko NN
    World J Exp Med; 2024 Mar; 14(1):89319. PubMed ID: 38590307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy.
    Koo TR; Eom KY; Kim IA; Cho JY; Yoon YS; Hwang DW; Han HS; Kim JS
    Radiat Oncol J; 2014 Jun; 32(2):63-9. PubMed ID: 25061574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUF2 Expression in Cancer Tissues and Lymph Nodes Suggests Post-Surgery Recurrence of Non-Small Cell Lung Cancer.
    Shirakami C; Ikeda K; Hinokuma H; Nishi W; Shinchi Y; Matsubara E; Osumi H; Fujino K; Suzuki M
    Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical resection and survival of patients with unsuspected single node positive lung cancer (NSCLC) invading the descending aorta.
    Wex P; Graeter T; Zaraca F; Haas V; Decker S; Bugdayev H; Ebner H
    Thorac Surg Sci; 2009 Jul; 6():Doc02. PubMed ID: 21289904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-exome sequencing reveals an association of rs112065068 in TGOLN2 gene with distant metastasis of non-small cell lung cancer.
    Gerashchenko T; Skitchenko R; Korobeynikova A; Kuanysheva K; Khozyainova A; Vorobiev R; Rodionov E; Miller S; Topolnitsky E; Shefer N; Anisimenko M; Zhuikova L; Vashisth M; Pankova O; Perelmuter V; Rezapova V; Artomov M; Denisov E
    Gene; 2024 Aug; 920():148507. PubMed ID: 38670394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of lung recurrence in patients with biliary tract cancer.
    Sumiyoshi T; Uemura K; Shintakuya R; Okada K; Serikawa M; Ishii Y; Arihiro K; Murakami Y; Murashita J; Takahashi S
    Langenbecks Arch Surg; 2023 Jul; 408(1):290. PubMed ID: 37522989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.